MORPHINE SULFATE
| Brand name | MORPHABOND ER |
|---|---|
| Active ingredient | MORPHINE SULFATE |
| Strength | 60MG |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2015 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7955619 | August 2028 | product |
| 10314788 | August 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.